Serum vitamin C concentration is low in peripheral arterial disease and isassociated with inflammation and severity of atherosclerosis

Citation
M. Langlois et al., Serum vitamin C concentration is low in peripheral arterial disease and isassociated with inflammation and severity of atherosclerosis, CIRCULATION, 103(14), 2001, pp. 1863-1868
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
103
Issue
14
Year of publication
2001
Pages
1863 - 1868
Database
ISI
SICI code
0009-7322(20010410)103:14<1863:SVCCIL>2.0.ZU;2-F
Abstract
Background-Peripheral arterial disease (PAD) is a severe atherosclerotic co ndition frequently accompanied by inflammation and oxidative stress. We hyp othesized that vitamin C antioxidant levels might be low in PAD and are rel ated to inflammation and disease severity. Methods and Results-We investigated vitamin C (L-ascorbic acid) levels in 8 5 PAD patients, 106 hypertensives without PAD, and 113 healthy subjects, Se rum L-ascorbic acid concentrations were low among PAD patients (median, 27. 8 mu mol/L) despite comparable smoking status and dietary intake with the o ther groups (P<0.0001). Subclinical vitamin C deficiency (<11.4 mu mol/L), confirmed by low serum alkaline phosphatase activity, was found in 14% of t he PAD patients but not in the other groups. Serum C-reactive protein (CRP) concentrations were significantly higher in PAD patients (P<0.0001) and ne gatively correlated with L-ascorbic acid levels (r=-0.742, P<0.0001). In st epwise multivariate analysis, low L-ascorbic acid concentration in PAD pati ents was associated with high CRP level (P=0.0001), smoking (P=0.0009), and shorter absolute claudication distance on a standardized graded treadmill test (P=0.029), Conclusions-Vitamin C concentrations are lower in intermittent claudicant p atients in association with higher CRP levels and severity of PAD. Future s tudies attempting to relate vitamin C levels to disease occurrence should i nclude in their analysis an inflammatory marker such as CRP.